934823-49-1
Urelumab
CAS: 934823-49-1
Molecular Formula:
934823-49-1 - Names and Identifiers
| Name | Urelumab |
| Synonyms | Urelumab |
| CAS | 934823-49-1 |
934823-49-1 - Introduction
Urelumab is an immune antibody used to treat certain types of cancer, particularly breast and colorectal cancer. It is a monoclonal antibody that blocks the undesirable proliferation and spread of cancer cells by binding to proteins on the surface of specific cancer cells.
Urelumab is prepared by biotechnology. First, a specific antigen is injected into the animal to provoke an immune response. After that, the lymphocytes that can efficiently bind the antigen are selected and fused to the special lymphoblastoma cells to form the hybridoma. Finally, cells containing the specific antibody are collected from the hybridoma, cultured and purified to obtain Urelumab.
The dosage and duration of use of Urelumab should be according to the doctor's prescription. During use, there may be some side effects, such as pain, nausea, vomiting, diarrhea, rash, etc. In addition, Urelumab may also cause immune-related adverse reactions, such as allergic reactions, inflammatory reactions, and immunosuppression.
However, Urelumab has important clinical value in the treatment of cancer and is widely used in clinical practice. Before or during use, patients should discuss in detail with their doctor and understand the possible risks and benefits in order to make an informed treatment decision.
Urelumab is prepared by biotechnology. First, a specific antigen is injected into the animal to provoke an immune response. After that, the lymphocytes that can efficiently bind the antigen are selected and fused to the special lymphoblastoma cells to form the hybridoma. Finally, cells containing the specific antibody are collected from the hybridoma, cultured and purified to obtain Urelumab.
The dosage and duration of use of Urelumab should be according to the doctor's prescription. During use, there may be some side effects, such as pain, nausea, vomiting, diarrhea, rash, etc. In addition, Urelumab may also cause immune-related adverse reactions, such as allergic reactions, inflammatory reactions, and immunosuppression.
However, Urelumab has important clinical value in the treatment of cancer and is widely used in clinical practice. Before or during use, patients should discuss in detail with their doctor and understand the possible risks and benefits in order to make an informed treatment decision.
Last Update：2024-04-09 21:01:54
Supplier List
Spot supply
Product Name: Urelumab Request for quotationCAS: 934823-49-1
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365
Wechat: 18916960931
Spot supply
Product Name: Urelumab Visit Supplier Webpage Request for quotationCAS: 934823-49-1
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Urelumab Visit Supplier Webpage Request for quotationCAS: 934823-49-1
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: Urelumab Request for quotationCAS: 934823-49-1
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365
Wechat: 18916960931
Spot supply
Product Name: Urelumab Visit Supplier Webpage Request for quotationCAS: 934823-49-1
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922
Wechat: 18621343501
WhatsApp: +86-18621343501
Spot supply
Product Name: Urelumab Visit Supplier Webpage Request for quotationCAS: 934823-49-1
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
View History